58 /100
HIGH RISK
Score updated Jul 14, 2026

NRXS — NeurAxis, Inc. Dilution Risk Tracker

Track NRXS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NRXS — Get alerts when the score changes →

As of July 14, 2026, NeurAxis, Inc. (NRXS) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. NeurAxis, Inc. has a market capitalization of $91.77M, 12.38M shares outstanding, 26 institutional holders tracked. Key dilution vectors include ATM program capacity of $11.50M, approximately 18 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
35%
🔁 Convertible Conversion 60%
• Major convertible overhang: 39849% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 18%
• Active ATM program with $12M remaining capacity
🔔 Track NRXS — Get forecast alerts →

💹 Market Data

Market Cap$91.77M
Shares Outstanding12.38M
Float8.48M
Cash$7.08M
Debt$329.1K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 44.8% shares (2026Q1 vs prior)
26 institutional holders · 2.28M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 451.7K shares
#2 AIGH Capital Management LLC 400.0K shares
#3 Rosalind Advisors, Inc. 286.1K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest358.7K
Days to Cover3.6
% of Float4.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
8-K 8K EVENT Apr 22, 2026
424B5 ATM Apr 21, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NRXS Shareholders

NeurAxis, Inc. (NRXS) has a DilutionScore of 58/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

NRXS has an active ATM (at-the-market) program with $11.5M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. Cash runway is a key watch item: NRXS has approximately 18 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for NRXS in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for NRXS alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work →
Track NRXS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NRXS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NRXS
📊 NRXS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NRXS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.